|
|
|
|
| LEADER |
00000cam a2200000Ii 4500 |
| 001 |
EBSCO_ocn991595841 |
| 003 |
OCoLC |
| 005 |
20231017213018.0 |
| 006 |
m o d |
| 007 |
cr cnu|||unuuu |
| 008 |
170626s2017 nyua ob 001 0 eng d |
| 040 |
|
|
|a N$T
|b eng
|e rda
|e pn
|c N$T
|d N$T
|d EBLCP
|d OCLCF
|d OCLCQ
|d IGB
|d AUW
|d BTN
|d MHW
|d INTCL
|d SNK
|d G3B
|d S8I
|d S8J
|d STF
|d D6H
|d OCLCQ
|d OCLCO
|d OCLCQ
|
| 020 |
|
|
|a 9781536120882
|q (electronic bk.)
|
| 020 |
|
|
|a 153612088X
|q (electronic bk.)
|
| 020 |
|
|
|z 9781536120691
|
| 035 |
|
|
|a (OCoLC)991595841
|
| 050 |
|
4 |
|a R850
|
| 072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 616
|2 23
|
| 049 |
|
|
|a UAMI
|
| 245 |
0 |
0 |
|a Advances in medicine and biology.
|n Volume 122 /
|c Leon V. Berhardt, editor.
|
| 264 |
|
1 |
|a New York :
|b Nova Biomedicakl,
|c [2017]
|
| 300 |
|
|
|a 1 online resource :
|b illustrations
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 588 |
0 |
|
|a Online resource; title from PDF title page (EBSCO, viewed June 24, 2017).
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
|
|a Preface; Chapter 1; Bacterial Biofilms: The Structure, Development and Potential of Plant Compounds for Alternative Control; Abstract; 1. Introduction; 2. Microbial Biofilms: Definition and Structure; 3. Biofilm Development; 4. Importance of the Biofilms; 4.1. Medical Importance: Biofilms and Pathogenesis; 4.2. Biofilm Industrial Problems; 4.2.1. Biofilms and Food Industry; 4.2.2. Biofilm and Fuel Industry; 5. Plant-Derived Products for Biofilm Control; Conclusion; Acknowledgments; References; Chapter 2; Bactericidal Agents: Common Mechanisms of Action and Strategy; Abstract.
|
| 505 |
8 |
|
|a 1. Introduction2. Membrane Targeting Mechanism; 2.1. Changes in Membrane Potential; 2.2. Leakage of Intracellular Cmponetns; 2.3. Pore Formation; 3. Stimulation of Intracellular Signaling; 3.1. Reactive Oxygen Species (ROS) Generation; 3.2. Filamentation and Cell Cycle Arrest; 3.3. The SOS Response and RecA protein; 3.4. Hallmarks of Eukaryotic Apoptotic Death; 4. Targeting the Cell Wall; Conclusion; References; Biographical Sketch; Chapter 3; Food Choices after Bariatric Surgery: Are There Changes in Oral Medium Characteristics and Food Perception?; Abstract; 1. Introduction.
|
| 505 |
8 |
|
|a 2. Bariatric Surgery2.1. Bariatric Surgery, Weight Loss, and Eating Behavior; 2.2. Hormonal/Post-Ingestive Changes Induced by Bariatric Surgery; 3. Oral Food Perception; 3.1. Mechanisms Involved in Flavor Perception; 3.2. Basics of Taste Anatomy and Physiology; 3.2.1. Influences of Hormones and Gastrointestinal Peptides in the Taste System; 3.3. Basics of Aroma Perception; 3.4. Changes in Oral Food Perception after Bariatric Surgery; 3.4.1. Changes in Taste Function; 3.4.2. Changes in Aroma/Odor Perception; 4. Saliva: An Important Fluid in Oral Food Perception.
|
| 505 |
8 |
|
|a 4.1. Saliva Secretion, Composition, and Functions4.2. Relation between Saliva Composition and Food Intake: Potential Effect of Changes to Dietary Regimens; 4.3. Saliva Changes Induced by Lifestyle Factors; 4.4. Saliva and Taste Perception; 4.5. Changes in Saliva Composition in Obesity and Bariatric Surgery; Conclusion; Acknowledgments; References; Chapter 4; Taxane-Induced Peripheral Neurotoxicity: A Review; Abstract; 1. Introduction; 2. Clinical Features; 2.1. Incidence and Severity of TIPN; 2.1.1. Paclitaxel-Induced Peripheral Neuropathy; 2.1.2. Docetaxel-Induced Peripheral Neuropathy.
|
| 505 |
8 |
|
|a 2.1.3. Comparison Paclitaxel with Docetaxel2.2. Clinical Manifestation and Evolution of TIPN; 2.2.1. The Symptoms; 2.2.2. Paclitaxel-Associated Acute Pain Syndrome; 2.3. Risk Factor of TIPN; 2.4. Other Drugs Causing Frequently CIPN; 2.4.1. Platinum Compounds; 2.4.2. Vincristine; 2.4.3. Eribulin; 2.4.4. Bortezomib; 2.4.5. Thalidomide; 2.5. Other Drugs Causing Less Frequently CIPN; 2.6. Neuropathy Assessment Tools; 3. Mechanism of TIPN; 3.1. Pathogenesis; 3.2. Pharmacogenomics of TIPN; 3.2.1. Genetic Variants Increasing Risk for Developing TIPN.
|
| 590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
| 650 |
|
0 |
|a Clinical medicine.
|
| 650 |
|
0 |
|a Biology
|x Research.
|
| 650 |
|
2 |
|a Clinical Medicine
|
| 650 |
|
6 |
|a Médecine clinique.
|
| 650 |
|
6 |
|a Biologie
|x Recherche.
|
| 650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a Biology
|x Research.
|2 fast
|0 (OCoLC)fst00832448
|
| 650 |
|
7 |
|a Clinical medicine.
|2 fast
|0 (OCoLC)fst00864361
|
| 700 |
1 |
|
|a Berhardt, Leon V.,
|e editor.
|
| 856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1540101
|z Texto completo
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL4882771
|
| 938 |
|
|
|a EBSCOhost
|b EBSC
|n 1540101
|
| 994 |
|
|
|a 92
|b IZTAP
|
